Yield10 Bioscience
YTEN
Yield10 Bioscience (YTEN) - Total debt
Total debt on the balance sheet as of December 2023 : $3.2 M
According to Yield10 Bioscience's latest financial reports the company's total debt is $3.2 M. A company’s total debt is the sum of all current and non-current debts.
Yield10 Bioscience - Total debt on balance sheet (from 2004 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $2.73 M | -15.74% |
| 2021-12-31 | $3.24 M | -14.89% |
| 2020-12-31 | $3.8 M | -10.86% |
| 2019-12-31 | $4.27 M | -34.43% |
| 2018-12-31 | $6.51 M | 309.75% |
| 2017-12-31 | $1.59 M | 40.46% |
| 2016-12-31 | $1.13 M | |
| 2015-12-31 | $N/A | |
| 2005-12-31 | $0.06 M | -86.86% |
| 2004-12-31 | $0.47 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | $0.8 M | -74.88% | Bahamas |
 NRC Health
NRC | $36.68 M | 1,044.59% | 🇺🇸 USA |